Opioid agonist treatment prevents hundreds of suicides: Study Australian research predicts the treatment has prevented around 300 suicide deaths among NSW patients with opioid use disorder.
Changes coming to MBS telehealth regulations The changes, coming into effect from 1 November, will be tied to a patient’s registered MyMedicare practice.
TGA updates montelukast safety information Extra information is being added to all products to highlight the existing warnings, as a ‘reminder to watch out’ for side effects.
Do GPs know enough about this ‘debilitating’ disorder? Experts agree there has been a dire lack of education around PMDD, but GPs could be in the ‘ideal situation’ to help.
New guide to support GPs ease cancer recurrence anxiety With 60% of patients anxious their cancer will return, the three-step clinical pathway is designed to offer practical and streamlined advice.
Study links childhood asthma to memory difficulties It found patients had a lower ability to remember specific events, but one GP urged caution, warning it may create ‘unnecessary concern’.
In Practice: Call for GPs to join dementia study New research aims to gather GPs’ understanding of and attitudes to dementia diagnosis and management, and the use of blood-based biomarkers.
New National Sustainable Asthma Care Roadmap released Each year, Australian inhalers cause the same greenhouse impact as 350,000 cars, but experts have found a way to help both patients and the climate.
Promising new treatment for incurable prostate cancer Groundbreaking Australian research has unveiled a promising new treatment for patients with aggressive and therapy-resistant cancer.
Federal Government reveals long-awaited Better Access response It says the mental health system is ‘difficult to navigate’, but supported less than half of the recommendations in full.